fMRI predicts response to liver tumor treatment

May 1, 2008 Diagnostic Imaging. fMRI predicts response to liver tumor treatment H. A. Abella -------------------------------------------------------------------------------- Contrast enhancement and metabolic changes detected with functional MR imaging can help interventional radiologists anticipate the effects of transarterial chemoembolization on primary and metastatic tumors of the liver. Clinical trials from Johns Hopkins University and Northwestern University come on the heels of a third study showing that contrast-enhanced and diffusion-weighted MRI can confirm the effects of transarterial chemoembolization (TACE) on liver metastases from neuroendocrine tumors. Results were presented March 17 at the 2008 Society of Interventional Radiology meeting.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC